Lack of complex N -glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry function

Abstract The HIV-1 envelope glycoprotein complex (Env) is the focus of vaccine development aimed at eliciting humoral immunity. Env's extensive and heterogeneous N -linked glycosylation affects folding, binding to lectin receptors, antigenicity and immunogenicity. We characterized recombinant E...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Virology (New York, N.Y.) N.Y.), 2010-06, Vol.401 (2), p.236-247
Hauptverfasser: Eggink, Dirk, Melchers, Mark, Wuhrer, Manfred, van Montfort, Thijs, Dey, Antu K, Naaijkens, Benno A, David, Kathryn B, Le Douce, Valentin, Deelder, André M, Kang, Kenneth, Olson, William C, Berkhout, Ben, Hokke, Cornelis H, Moore, John P, Sanders, Rogier W
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract The HIV-1 envelope glycoprotein complex (Env) is the focus of vaccine development aimed at eliciting humoral immunity. Env's extensive and heterogeneous N -linked glycosylation affects folding, binding to lectin receptors, antigenicity and immunogenicity. We characterized recombinant Env proteins and virus particles produced in mammalian cells that lack N -acetylglucosaminyltransferase I (GnTI), an enzyme necessary for the conversion of oligomannose N -glycans to complex N -glycans. Carbohydrate analyses revealed that trimeric Env produced in GnTI−/− cells contained exclusively oligomannose N -glycans, with incompletely trimmed oligomannose glycans predominating. The folding and conformation of Env proteins was little affected by the manipulation of the glycosylation. Viruses produced in GnTI−/− cells were infectious, indicating that the conversion to complex glycans is not necessary for Env entry function, although virus binding to the C-type lectin DC-SIGN was enhanced. Manipulating Env's N -glycosylation may be useful for structural and functional studies and for vaccine design.
ISSN:0042-6822
1096-0341
DOI:10.1016/j.virol.2010.02.019